MAPT and Alzheimer disease: Loss or reduction of Reelin results in disinhibited GSK3β activity and elevated tau phosphorylation, a mechanism confirmed in AD mouse models and human tissue (Rossi et al., 2020; Mouofo and Spires-Jones, 2023).